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ABSTRACT 
 
Background: Tuberculosis is a life threatening disease that is partially prevented by 
BCG vaccine. Development of more effective vaccines is an urgent priority in TB 
control. Ag85a and Tb10.4 are the members of culture filter protein (CFP) of M. 
tuberculosis that have high immunogenicity. Objective: To analyze the 
immunogenicity of Ag85a-Tb10.4 DNA vaccine by enzyme-linked immunosorbent 
assay (ELISA). Methods: In this study a previously described plasmid DNA vaccine 
encoding Ag85a-Tb10.4 was used to examine its capability in the stimulation of 
immune responses in an animal model. Female BALB/c mice were vaccinated with 100 
μg of purified recombinant vector intramuscularly 3 times at two-week intervals and the 
levels of five cytokines including IFN-γ, IL-12, IL-4, IL-10 and TGF-β were measured. 
Results: The levels of IFN-γ and IL-12 for the mice following immunization with 
Ag85A-Tb10.4 was significantly greater than that of the BCG and control group 
(p<0.05). However there was no significant difference in the levels of IL-4, IL-10 and 
TGF-β between groups. Conclusion: IFN-γ and IL-12 Th1 cytokines increased 
significantly in mice vaccinated with Ag85a-TB10.4 DNA vaccine in comparison to the 
control and BCG groups. Our results may serve as groundwork for further research into 
the prevention and treatment of tuberculosis. 
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